A promise of being Productive, Progressive and Price-conscious in the Indian pharmaceutical Segment: Oaknet Healthcare
Hailing from a family whose generation has been serving the nation as army personnel, he too, aspired to join the army. There, some complications and the solidarity that runs down in his veins diverted his focus and shaped him to blend out as a persona interwoven with a high sense of discipline, commitment, integrity & courage which proved out as the turning point for his journey ahead…
He is R.S. Raghav, an entrepreneur, a leader, and an avid reader who believes that Bhagavad Gita has all the philosophical answers, while ‘The fortune at the bottom of the pyramid’ tops the list of his favorite business books. This unquenchable thirst for knowledge has won him numerous trophies akin to ‘5thINDY’s MARCOM Professional of the Year 2011 – Pharmaceuticals’, ‘CMO Asia Awards for Excellence in Branding & Marketing’ and ‘Brand Leadership Award’ (2010) conferred by World Brand Congress 2010. His professional journey took off as a medical representative in 1985 in Fulford(India) and waved to Lupin in 1986. Mr. Raghav kept on building diverse capabilities as he played various roles such as Regional Sales Manager & General Manager, which ultimately chaired him as Lupin’s Executive Vice President. He further honed his plentiful hands-on knowledge by doing an MBA course in correspondence in 2000 and a certification course in ‘Aligning Strategy and Execution’ conducted by Harvard Business School, which aided him to understand the thought process of millennial generation. The profound capabilities and expertise in IPM and confidence in creating a better value for stakeholders prompted him to lay the foundation of his venture, Oaknet Healthcare in 2015.
Oaknet Healthcare is a pharmaceutical company with its core focus on NCDs (non-communicable diseases). With the acquisition of Indian Operation of South African MNC Adcock Ingram Healthcare in 2016, Oaknet Healthcare scaled up its operations. The expertise of R S Raghav and a distinguished team of experts combining 150 years of experience, significant achievements & status amongst the top 10 pharma companies in the Indian Pharmaceutical Market (IPM) translates into a differentiated value proposition and successfully delivers comprehensive healthcare services among the NCD business (Non Communicable Disease) i.e. Cardiology, diabetes, neurology. Value-integrated performance is the core strength of the team. Oaknet Healthcare Pvt Ltd enjoys the market presence of a legacy business of the Cosme Farma spanning close to four decades in such specialties as Dermatology, Gynaecology & Orthopaedics.
Creating the differentiator
“Where every human life is looked up with the same eye
Where health isn’t the treasure of just Privileged few
Where goodness of oak and greatness of net unite
That’s where Oaknet stands….To create Value…To Deliver Value”
Oaknet with tremendous leadership expertise in the IPM is poised to create history by scaling up revenues to INR 10 billion over the next 5 years through organic and inorganic growth. Specialities of focus are Cardiology, Diabetes, Dermatology, Gynaecology, Pain Management, Ophthalmology, and Neurology. With the acquisition of Adcock Ingram, Oaknet Healthcare became one of the fastest Indian Company to reach amongst the Top 100 Companies in the IPM. This deal gave Oaknet Healthcare access to the fast-growing dermatology & gynaecology segments with brands having a presence for 40 years in the country.
Routing an expertise of 3 decades in its offerings
Oaknet’s customer-centric product range is a blend of over 3 decade’s legacy in Dermatology & Gynaecology. Oaknet’s caters heritage brands like Cosvate & Flucos in Dermatology and Jectocos & Ferose in Gynaecology. The major focused therapy areas include Cardiology, Dermatology, Diabetology, Orthopedics, and others.
- Cardiology and Diabetology
- Oaknet Pharma
With a commitment towards providing global community with novel pharmaceutical products at the most affordable cost, Oaknet healthcare has expanded its export operations focused towards some prominently emerging markets like Sri Lanka, Myanmar, Cambodia, Kenya, Tanzania, Mauritius, and Jamaica. While experiencing a towering growth, Oaknet is actively seeking alliances in the Middle East and Central Asia, South and Central America and The European Union.
Oaknet Healthcare: Way forward
- Licensing of new products and technology platforms to differentiate in the branded generics space
- To be amongst top 15 player in dermatology segment
- Achieve industry-level EBITDA margin of 18%
- Improve Field-force productivity
- Digital Marketing initiatives to increase touch points with customers
- Identify acquisitions in focus therapy areas